-
公开(公告)号:US5399572A
公开(公告)日:1995-03-21
申请号:US084764
申请日:1993-06-28
申请人: Alfred R. Green , Alan J. Cross , Bernard R. Boar
发明人: Alfred R. Green , Alan J. Cross , Bernard R. Boar
IPC分类号: A61K31/425
CPC分类号: A61K31/425
摘要: A thiazole of the following formula is disclosed ##STR1## for the treatment of neurodegeneration involving loss of neuronal structure.
摘要翻译: 下列公式的噻唑被公开用于治疗涉及神经元结构丧失的神经退行性疾病。
-
公开(公告)号:US5385921A
公开(公告)日:1995-01-31
申请号:US744914
申请日:1991-08-14
IPC分类号: A61K31/425 , A61K31/426 , A61P9/00 , A61P9/10 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P43/00 , C07D277/22 , C07D277/24 , A01K31/425
CPC分类号: A61K31/425 , C07D277/24
摘要: New pharmaceutical formulations comprising 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole or optical isomers or a pharmaceutically acceptable salt or solvate thereof.
摘要翻译: 包含5-(2-氯-1-羟乙基)-4-甲基噻唑或光学异构体的新药物制剂或其药学上可接受的盐或溶剂化物。
-
公开(公告)号:US5585378A
公开(公告)日:1996-12-17
申请号:US467695
申请日:1995-06-06
申请人: Bernard R. Boar , Alan J. Cross
发明人: Bernard R. Boar , Alan J. Cross
IPC分类号: A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4427 , A61K31/445 , A61K31/495 , A61K31/55 , A61P25/00 , A61P25/28 , A61P27/02 , A61P43/00 , C07D209/34 , C07D209/38 , C07D211/18 , C07D401/06 , C07D403/06 , C07D491/10 , C07D491/113
CPC分类号: C07D401/06 , A61K31/445 , A61K31/495 , A61K31/55 , C07D209/34 , C07D209/38 , C07D403/06 , C07D491/10
摘要: The present invention relates to an oxindole compound having the formula 5-cyclohexyl-1,3-dihydro-1-[2-[4-(phenylmethyl)-1-piperazinyl]ethyl]-2H-indol-2-one for the prevention or treatment of cognitive dysfunctions.
摘要翻译: 本发明涉及具有式5-环己基-1,3-二氢-1- [2- [4-(苯基甲基)-1-哌嗪基]乙基] -2H-吲哚-2-酮的羟基吲哚化合物,用于预防 或治疗认知功能障碍。
-
4.1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their use as neuroprotective agents 失效
标题翻译: 1-杂唑基-1-杂环基烷烃衍生物及其用途及其作为神经保护剂的用途公开(公告)号:US5607956A
公开(公告)日:1997-03-04
申请号:US459847
申请日:1995-06-02
申请人: Robin B. Boar , Alan J. Cross , Duncan A. Gray , Richard A. Green
发明人: Robin B. Boar , Alan J. Cross , Duncan A. Gray , Richard A. Green
IPC分类号: C07D277/24 , A61K20060101 , A61K31/395 , A61K31/41 , A61K31/415 , A61K31/4178 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/44 , A61K31/443 , A61P9/10 , A61P25/00 , C07D20060101 , C07D207/00 , C07D207/32 , C07D207/33 , C07D231/12 , C07D233/58 , C07D233/64 , C07D249/02 , C07D261/06 , C07D263/30 , C07D263/32 , C07D271/02 , C07D273/00 , C07D275/02 , C07D277/20 , C07D277/22 , C07D277/26 , C07D277/28 , C07D285/01 , C07D291/04 , C07D293/04 , C07D293/06 , C07D307/00 , C07D401/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/06 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D417/14 , C07D421/06 , C07D421/14
CPC分类号: C07D405/06 , C07D413/06 , C07D417/06 , C07D417/14
摘要: The present invention relates to novel heterocyclic compounds having the general formula (1) ##STR1## geometric and optical isomers and racemates thereof where such isomers exist, as well as pharmaceutically acceptable acid addition salts thereof and solvates thereof;having therapeutic activity, processes and intermediates for their preparation, pharmaceutical formulations containing said compounds and the medicinal use of said compounds.
摘要翻译: 本发明涉及具有通式(1)的新型杂环化合物,其中存在这些异构体的几何和旋光异构体及其外消旋体,以及其药学上可接受的酸加成盐和溶剂合物; 具有治疗活性,其制备方法和中间体,含有所述化合物的药物制剂和所述化合物的医药用途。
-
-
-